Switzerland FOPH Food Supplements & Swissmedic Boundary: Trilingual Labelling and Lifecycle Readiness

Switzerland regulates food supplements under the Foodstuffs and Utility Articles Act (FSA), the Foodstuffs and Utility Articles Ordinance (FCSO) and the Food Supplement Ordinance (Verordnung über Nahrungsergänzungsmittel). The framework broadly aligns with EU Food Supplements Directive 2002/46/EC and EU Regulation 1924/2006 on nutrition and health claims through autonomous Swiss adoption — but Switzerland is not an EU member, the rules are independent Swiss law, and divergence exists in specific ingredient acceptability, permitted health-claim wording and labelling format. Food supplements under the Swiss framework are foods intended to supplement the normal diet, with concentrated sources of nutrients (vitamins, minerals) or other substances with nutritional or physiological effect, marketed in dose form (capsules, tablets, sachets, drops, ampoules, measured doses). FOPH/BAG operates as the federal competent authority for general rule-making and centralised matters; cantonal Lebensmittelvollzug (food enforcement) authorities conduct retail enforcement, sampling and post-market surveillance with substantial divergence in intensity across the 26 cantons. Notification of food supplements to the cantonal authority is typically required before placing on the Swiss market depending on the canton and the product category.

Swissmedic (Swiss Agency for Therapeutic Products) regulates medicinal products under the Therapeutic Products Act (Heilmittelgesetz, HMG). The food/medicine boundary is determined by product presentation, ingredients and claims — products presented as therapeutic, making medicinal claims (treats, prevents, cures), or containing ingredients with pharmacological action above food-supplement threshold doses fall under Swissmedic medicinal product regulation requiring marketing authorisation as either Allopathic Medicine or Complementary Medicine (Komplementärmedizin) including phytotherapy, homoeopathy, anthroposophic medicine and traditional Chinese/Tibetan/Ayurvedic medicine. The Complementary Medicine pathways offer streamlined authorisation routes for traditional and homeopathic products with reduced evidence requirement relative to allopathic drug authorisation. Boundary cases include herbal products at higher dose, glucosamine and chondroitin marketed for joint conditions, melatonin (medicinal product in Switzerland regardless of dose vs general supplement status in some EU member states), and probiotic products marketed with specific clinical claims. Misclassification — marketing a Swissmedic-required product as food supplement — triggers Swissmedic enforcement including market withdrawal and potential prosecution.

Swiss food supplement ingredient acceptability is broadly aligned with EU Food Supplements Directive Annexes — permitted vitamin and mineral forms, maximum levels in specific cases — but with Swiss-specific deviations including specific positive and negative lists for botanical ingredients maintained by FOPH/BAG, and specific Swiss restrictions on certain ingredients (e.g. higher caffeine threshold for energy products, specific botanical restrictions). Health claims are governed by Swiss adoption of EU Regulation 1924/2006 with the EFSA permitted health claim register broadly recognised — but Swiss-specific approvals, translation requirements and labelling format apply. Novel food status in Switzerland is governed under the Swiss Novel Food Ordinance with substantial alignment to EU Regulation 2015/2283 but independent Swiss application — novel ingredients require Swiss-specific authorisation. Cross-border supply: products lawfully marketed in EU member states may benefit from Cassis-de-Dijon mutual recognition under the bilateral Switzerland-EU agreements for general food, but food supplements are subject to specific Swiss requirements that limit the EU-mutual-recognition pathway in practice. Brand-owners typically maintain Swiss-specific product registration regardless of EU compliance.

Swiss food labelling under the Foodstuffs Ordinance and Information on Foodstuffs Ordinance requires every mandatory label element to appear in at least one official Swiss language, with the practical commercial expectation being trilingual German, French and Italian content covering the three Swiss linguistic regions. Mandatory elements include product name, ingredient list with quantitative declaration where relevant, allergen declaration in line with Swiss allergen list (broadly aligned with EU allergen list), nutrition information per the Swiss format, recommended daily intake, recommended consumption method, suitable and unsuitable population statements, warnings, manufacturer/importer details, lot identification, durability date and storage conditions. Romansh (the fourth official Swiss language) is not commercially required. Sloppy or machine-translated French and Italian labelling is a common cantonal-enforcement finding — Swiss consumer media and complaint processes are active. Region-specific allergen list deviations from EU (some elements differ) and Swiss-specific allergen labelling format are frequent compliance gaps for EU-format labels.

Swiss food enforcement is largely cantonal — the 26 cantons each operate Lebensmittelvollzug authorities conducting sampling, label review and retail enforcement with substantial divergence in intensity, sectoral focus and procedural approach. Zurich, Geneva, Basel-Stadt and Bern cantons are typically the most active enforcement environments and the largest commercial markets. Cantonal findings can result in product confiscation, sales prohibition, mandatory corrective action and prosecution under the FSA. Post-market surveillance includes targeted sampling of high-risk supplement categories (sports, weight-loss, sexual-enhancement, herbal preparations) with regular finding publication. Swiss adverse event reporting for food supplements operates through the Swiss Tox Info Suisse and FOPH channels with specific reporting expectation for serious adverse events. The Swiss commercial discipline is rigorous — Swiss consumer expectations of label accuracy, ingredient transparency, certification status and sustainability are among the highest globally. Premium positioning is the dominant commercial model for the Swiss supplement market; bulk-channel competition with low-cost imports is structurally constrained by Swiss retail pricing and consumer preference for trusted brands.